GSK · NYSE
Weekly Buzz:CIPLA, VTRS Win FDA Nod; BSX Cuts Jobs; ARGX Snaps Up FBRX; JNJ, GSK Strike Deals
IONS Beats Q2 Earnings & Sales Estimates, Reiterates '26 Outlook
GSK Strikes $110M AI Deal With Relation Therapeutics To Boost Early Pipeline
GSK Strikes $100M AI Deal With Relation Therapeutics To Boost Early PipelineModerna Q2 Earnings Loom: Buy or Sell the Stock Ahead of Results?GSK Beats Q2 Earnings & Revenue Estimates, Announces Cost-Saving PlanGilead to Report Q2 Earnings: How Should You Play the Stock Now?